CEBPZ and acute myeloid leukemia: Nevertheless, given that these studies excluded or did not specifically analyze patients with CBF-AML, and that the proportion of CBF-AML decreases with age[33, 34], very few data were published about HMA efficacy in the specific CBF-AML subset.